Akihiko Kawahara
Overview
Explore the profile of Akihiko Kawahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshimitsu T, Nishio S, Park J, Nasu H, Matsukuma K, Tasaki K, et al.
Kurume Med J
. 2025 Mar;
PMID: 40058870
Enhanced oncogenic Y-box binding protein-1 (YB-1) expression, associated with the aberrant expression of genes involved in cell proliferation, survival, and drug resistance, can predict prognostic outcomes in patients with various...
2.
Naito Y, Kawahara A, Makino R, Tokumitsu T, Nagayama D, Sadashima E, et al.
Acta Cytol
. 2025 Mar;
:1-18.
PMID: 40024239
Introduction: The use of liquid-based cytology (LBC) in non-gynecological fields has progressively increased. However, studies focusing on the application of LBC in bile cytology are limited, and its efficacy remains...
3.
Murata D, Azuma K, Nishii Y, Murotani K, Matama G, Kawahara A, et al.
Chemotherapy
. 2025 Jan;
:1-7.
PMID: 39842417
Introduction: Identifying the underlying mechanisms of immune checkpoint inhibitor resistance in patients with cachexia is a current challenge. Ghrelin is a peptide hormone that plays an important role in the...
4.
Murakami Y, Katsuchi D, Matsumoto T, Kanazawa K, Shibata T, Kawahara A, et al.
Sci Rep
. 2024 Sep;
14(1):21701.
PMID: 39289424
Y-box binding protein 1 (YBX1) promotes oncogenic transformation and tumor growth. YBX1 plays a role in regulation of cell cycle promotion via upregulation of cell cycle-related genes. In ovarian cancer,...
5.
Murata D, Azuma K, Murotani K, Kawahara A, Nishii Y, Tokito T, et al.
Cancer Immunol Immunother
. 2024 Sep;
73(11):214.
PMID: 39235457
Background: Despite the favorable therapeutic efficacy observed with ICI monotherapy, the majority of non-small cell lung cancer (NSCLC) patients do not respond. Therefore, identifying patients who could optimally benefit from...
6.
Fukuda J, Sudo T, Kikuchi M, Kawahara A, Shigyo H, Kawamoto Y, et al.
Anticancer Res
. 2024 Jul;
44(8):3567-3575.
PMID: 39060055
Background/aim: There are no established biomarkers for immune checkpoint inhibitors (ICI) in colorectal cancer (CRC) with microsatellite stability (MSS) or proficient mismatch repair (pMMR). Therefore, this study aimed to identify...
7.
Abe H, Kawahara A, Akiba J, Yamaguchi R
Cytopathology
. 2024 Jun;
35(6):682-694.
PMID: 38837293
Liquid-based cytology (LBC) has changed the landscape of gynaecological cytology. A growing demand exists for LBC in diagnostic cytology, particularly for ancillary testing, such as immunocytochemistry and molecular testing. Ancillary...
8.
Todoroki K, Abe Y, Matsuo K, Nomura H, Kawahara A, Nakamura Y, et al.
Oncol Lett
. 2024 Jan;
27(2):79.
PMID: 38249811
The relationship between cancer stem cells (CSCs) in oral squamous cell carcinoma (OSCC) and programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) remains unclear. Therefore, the present study...
9.
Harada H, Ono T, Abe H, Kawahara A, Nakatsuka S, Honma K, et al.
Kurume Med J
. 2023 Oct;
69(1.2):103-109.
PMID: 37793887
Small cell carcinoma is rare in salivary glands and has recently been termed small cell neuroendocrine carcinoma. We herein describe an uncommon example arising in the parotid gland. The patient...
10.
Murata D, Azuma K, Matsuo N, Murotani K, Matama G, Kawahara A, et al.
Cancer Med
. 2023 Sep;
12(19):19471-19479.
PMID: 37712645
Background: The presence of cachexia negatively impacts the prognosis of patients with cancer. However, the mechanisms behind the development of cachexia and its prognostic impact on immunotherapy efficacy are not...